Evidence map›Paper›PMID 25864914›Full record

ArticleCellular & molecular immunology2015

Overview of the special issue on HBV immunity.

Antonio Bertoletti, Fu-Sheng Wang

Abstract readEditorial
In one paragraph

Article in Cellular & molecular immunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Restoration of HBV-specific CD8Signal transduction and targeted therapy · 2021
    Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Natural killer cells in liver diseases.Frontiers of medicine · 2018
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Antonio Bertoletti1] Emerging infectious Diseases, Duke-NUS Medical School, Singapore, Singapore [2] Singapore Institute for Clinical Sciences, A*STAR, Singapore, Singapore.
Fu-Sheng WangResearch Center for Biological Therapy, The Institute of Translational Hepatology, Beijing, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

AnimalsBiological EvolutionBlood PlateletsB-LymphocytesHepatitis B, ChronicHepatitis B virusHumansImmunityInterleukin-21InterleukinsKiller Cells, NaturalInterleukin-21Interleukins

Identifiers

PMID25864914
PMCPMC4654325

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.